Listing & Compliance Notices

TOMI Environmental Solutions, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“November 17, 2025, TOMI Environmental Solutions, Inc. (the “Company”) received a deficiency letter from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market (“Nasdaq”) notifying the Company that, for the preceding 30 consecutive business days, the closing bid price for the Company’s common stock, par value $0.01 per share (the “Common Stock”) was below the minimum $1.00 per share requirement for continued inclusion on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Requirement”). The notification received has no immediate effect on”

Greenwave Technology Solutions, Inc. received a nasdaq delisting notice notice regarding late filing (rules 5250(c)(1)).

“ing. On November 18, 2025, Greenwave Technology Solutions, Inc., a Delaware corporation (the “Company”), received a Staff Determination Letter (the “Staff Determination Letter”) from the Nasdaq Listing Qualifications Staff (the “Staff”) based on the Company’s non-compliance with Nasdaq Listing Rule 5250(c)(1) (the “Filing Rule”), as previously notified by the Staff on May 23, 2025 and August 22, 2025. The basis for the Staff Determination Letter is that the Company has not yet filed its Quarterly Reports on Form 10-Q for the periods ended March 31, 2025, June 30, 2025 and September 30, 2025, w”

IP STRATEGY HOLDINGS, INC. received a nasdaq compliance regained notice regarding minimum bid price (rules 5550(a)(2)).

“November 19, 2025, the Company received a letter from Nasdaq stating that, as the closing bid price of the Common Stock has been at $1.00 per share or greater for the ten consecutive business days from November 5, 2025 to November 18, 2025, the Staff has determined that the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2) and has closed the matter.”

BRC Group Holdings, Inc. received a nasdaq hearing update notice regarding late filing (rules 5250(c)(1)).

“November 18, 2025, B. Riley Financial, Inc. (the “Company”) received written notification (the “Decision Letter”) from the Nasdaq Hearings Panel (the “Panel”) notifying the Company of its decision to grant the Company’s request to continue its listing on The Nasdaq Stock Market (“Nasdaq” or the “Exchange”), subject to the Company’s meeting certain conditions outlined in the letter. The Company participated in a hearing with the Panel on November 4, 2025 in connection with the Company’s non-compliance with Nasdaq Listing Rule 5250(c)(1) (the “Filing Rule”), as previously notified by the Nasdaq”

CaliberCos Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“August 27, 2025, on August 27, 2025, CaliberCos Inc. (the “Company”) received a notification letter from the Nasdaq Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that its amount of stockholders’ equity had fallen below the $2,500,000 required minimum for continued listing set forth in Nasdaq Listing Rule 5550(b)(1) (the “Listing Rule”). On November 17, 2025, the Company received a letter from Nasdaq stating that based on the Company’s Form 10-Q for the period ended September 30, 2025, evidencing stockholders’ equity of $6,087,000, th”

reAlpha Tech Corp. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2)).

“November 18, 2025, the Company received a second letter from the Staff granting the Company’s request for a 180-day extension to regain compliance with the Minimum Bid Price Requirement. The Company now has until May 18, 2026 (the “Additional Compliance Period”), to regain compliance with the Minimum Bid Price Requirement. This determination was based on the Company meeting the continued listing requirement for the market value of publicly held shares and all other initial listing standards for the Nasdaq Capital Market, except for the Minimum Bid Price Requirement, and the Company’s written n”

SOLIGENIX, INC. received a nasdaq compliance regained notice regarding stockholders equity (rules 5550(b)(1)).

“November 18, 2025, the Company received a letter from Nasdaq confirming that the Company had regained compliance with the Shareholders’ Equity Requirement and that the matter is now closed. ​”

Shuttle Pharmaceuticals Holdings, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. Shuttle Pharmaceuticals Holdings, Inc. (the “Company”) reported stockholders’ equity of $1,394,161 in its Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2025, and, as a result, was not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires”

Kaival Brands Innovations Group, Inc. received a nasdaq delisting notice notice regarding other.

“November 10, 2025, the Company received a letter (the “Notice”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) that stated the Staff’s belief that the Company is a public shell” and the continued listing of its securities is no longer warranted. In the Notice, the Staff explained that it based this belief on its review of the Company’s public disclosures and materials submitted to the Staff by the Company. The Staff further stated that such belief is supported by the Company’s lack of revenue generating assets and the substantial reduction in”

ECD Automotive Design, Inc. received a nasdaq deficiency notice notice regarding other (rules 5635(d)).

“November 11, 2025, ECD Automotive Design, Inc. (the “Company”) received a telephone call (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, the warrant the Company issued to pay outstanding legal fees on September 24, 2025 (the “Warrant”) violated Nasdaq Rule 5635(d) (the “Rule”). The Company amended the Warrant on October 1, 2025 to make the Warrant compliant with the Rule. Nasdaq requested that the Company publicly disclose that the Company was in violation of the Rule upon issuance of the Warrant and that the Company regained compliance with the Rule when”

INSPIRE VETERINARY PARTNERS, INC. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)(iv)).

“November 13, 2025, Inspire Veterinary Partners, Inc. (the “Company”) received a notice letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, based upon the closing bid price of the Company’s common stock, par value $0.0001 per share, for the prior 30 consecutive business days, the Company was not in compliance with the minimum bid price requirement of Nasdaq Listing Rule 5550(a)(2). Further, the Notice stated that, pursuant to Listing Rule 5810(c)(3)(A)(iv), the Company was not eligible for any compliance period s”

BROADWAY FINANCIAL CORP \DE\ received a nasdaq extension granted notice regarding late filing (rules 5250(c)(1)).

“November 11, 2025, Broadway Financial Corporation (the “Company”) received an extension from The Nasdaq Stock Market LLC (“Nasdaq”) to February 16, 2026 (the “Extension Deadline”) for the Company to file its Quarterly Report on Form 10-Q for the quarter ended June 30, 2025 (the “Form 10-Q”) with the U.S. Securities and Exchange Commission, to regain compliance with Rule 5250(c)(1). The Company anticipates filing the Form 10-Q on or before the Extension Deadline. As previously reported, there is no immediate impact on the Company’s listing status on The Nasdaq Capital Market at this time. *”

Cycurion, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5450(a)(1)).

“November 11, 2025, the Company announced that it received a letter Nasdaq stating that Nasdaq has determined that the Company has regained compliance with Nasdaq’s Bid Price Rule requirement under Listing Rule 5450(a)(1). The Company is now in compliance with Nasdaq Global Market’s listing requirements. Additionally, Nasdaq confirmed that the previously scheduled hearing before the Nasdaq Hearings Panel on November 20, 2025 has been canceled. The Company’s securities will continue to be listed and traded on The Nasdaq Stock Market without interruption.”

PETMED EXPRESS INC received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“November 12, 2025, the Company received an expected notice (the “Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”), which indicated that, as a result of the Company’s delay in filing its Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2025 (the “Q2 10-Q”), in addition to its continued delinquency in filing its Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2025 (the “Q1 10-Q”), the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”), which requires Nasdaq-listed companies to timely file all required periodic”

Direct Digital Holdings, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“November 13, 2025, the Company received a second notice (the “ Second Notice ”) from the Staff stating that the Company did not regain compliance with the Bid Price Rule by November 10, 2025, was not eligible for a second 180-day period to remedy the deficiency, and, as a result, non-compliance with the Bid Price Rule could serve as an additional basis for delisting. As described below, the Company previously presented its plan to evidence compliance with the Bid Price Rule at a hearing before the Nasdaq Hearings Panel, which subsequently granted the Company an extension to regain compliance w”

Armlogi Holding Corp. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).

“November 7, 2025, Armlogi Holding Corp. (the “Company”) received a notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the listing of its common stock was not in compliance with Nasdaq Listing Rule 5450(a)(1) for continued listing on the Nasdaq Global Market, as the closing bid price of the Company’s common stock was less than $1.00 per share for the previous 30 consecutive business days. The notice has no present impact on the listing of the Company’s securities, and the Company’s common stock continues to trade on the Nasdaq”

DORCHESTER MINERALS, L.P. received a nasdaq deficiency notice notice regarding audit committee (rules 5615(a)(4)(C), 5605(c)(2)(A), 5605, 5605(c)(4)).

“November 10, 2025, the Partnership received a letter from Nasdaq acknowledging the Partnership’s non-compliance with Nasdaq’s audit committee requirements as set forth in Nasdaq’s Listing Rule 5605. The Nasdaq letter further provides that, consistent with Nasdaq’s Listing Rule 5605(c)(4), Nasdaq will provide the Partnership a cure period in order to regain compliance as follows: (a) until the earlier of the Partnership’s next annual unitholders’ meeting or October 30, 2026; or (b) if the next annual unitholders’ meeting is held before April 28, 2026, then the Partnership must evidence complian”

KALA BIO, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2), 5810(c)(3)(C)).

“November 10, 2025, KALA BIO, Inc. (the “Company”) received a deficiency letter from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market (“Nasdaq”) notifying the Company that the listing of its common stock was not in compliance with Nasdaq Listing Rule 5550(b)(2) (the “Minimum MVLS Requirement”) for continued listing on The Nasdaq Capital Market, as the market value of the Company’s listed securities was less than $35 million for the previous 30 consecutive business days. As of the date of this Current Report on Form 8-K, the Company does not meet the alternative sta”

ELUTIA INC. received a nasdaq deficiency notice notice regarding late filing (rules 5550(a)(2), 5810(c)(3)(A), 5810(c)(3)(H)).

“November 7, 2025, Elutia Inc., a Delaware corporation (the “Company” or “Elutia”), received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the last 30 consecutive business days, the closing bid price for the Company’s Class A common stock, par value $0.001 per share (the “Common Stock”), was below $1.00 per share, which is the minimum closing bid price (the “Minimum Bid Price”) required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Notice”). This Notice has no im”

GRAPHJET TECHNOLOGY received a nasdaq delisting notice notice regarding market value (rules 5450(b), 5450(b)(2)(A)).

“November 11, 2025, Graphjet Technology (the “ Company ”) received a written notice (the “ Notice ”) from a Hearings Advisor from the Office of the General Counsel of The Nasdaq Stock Market LLC indicating that the Nasdaq Hearings Panel (the “ Panel ”) has determined to delist the Company’s securities from The Nasdaq Global Market (“ Nasdaq ”). The Panel’s determination was based on the Company’s failure to regain compliance with Nasdaq Listing Rules 5450(b)(2&3)(C) and 5450(b)(2)(A), the market value of publicly held shares and market value of listed securities rules, respectively. Accordingly”

Allied Gaming & Entertainment Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“November 4, 2025, Allied Gaming & Entertainment Inc. (the “Company”) received a deficiency letter from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market (“Nasdaq”) notifying the Company that, for the preceding 30 consecutive business days, the closing bid price for the Company’s common stock, par value $0.0001 per share (the “Common Stock”) was below the minimum $1.00 per share requirement for continued inclusion on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Requirement”). The notification received has no immediate effect”

PLAYSTUDIOS, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).

“November 5, 2025, PLAYSTUDIOS, Inc. (the “Company”) received a notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the listing of its Class A common stock was not in compliance with Nasdaq Listing Rule 5450(a)(1) for continued listing on the Nasdaq Global Market, as the closing bid price of the Company’s Class A common stock was less than $1.00 per share for the previous 30 consecutive business days. The notice has no present impact on the listing of the Company’s securities, and the Company’s Class A common stock continues to”

Foxx Development Holdings Inc. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2), 5810(c)(3)(C)).

“November 5, 2025, the Company received a deficiency letter (the “Letter”) from the Nasdaq Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for a period of 30 consecutive business days, the Company’s market value of listed securities (“MVLS”) closed below the $35,000,000 MVLS threshold required for continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(b)(2) (the “MVLS Rule”). In accordance with Nasdaq Listing Rule 5810(c)(3)(C), the Company has until May 4, 2026 to regain compliance with the MVLS Requir”

BIO KEY INTERNATIONAL INC received a nasdaq noncompliance notice notice regarding minimum bid price (rules 5550(a)(2)).

“November 6, 2025, the Company received a letter from Nasdaq (the “ Letter ”) stating that although the Company had not regained compliance with the Bid Price Rule, Nasdaq determined that the Company is eligible for an additional 180-day period, or until May 4, 2026, to regain compliance with the Bid Price Rule. In the Letter, Nasdaq stated that its determination was based on (i) the Company meeting the continued listing requirement for market value of its publicly held shares and all other applicable requirements for initial listing on the Nasdaq Capital Market with the exception of the minimu”

agilon health, inc. received a nyse deficiency notice notice regarding minimum bid price (rules 802.01C).

“November 5, 2025, agilon health, inc. (the “Company”) received written notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) informing the Company that it is no longer in compliance with Section 802.01C of the NYSE Listed Company Manual because the average closing price of the Company’s common stock was less than $1.00 per share over a consecutive 30 trading-day period ended November 4, 2025 (the “Price Criteria for Capital or Common Stock”). The Company can regain compliance at any time within the six-month period following receipt of the Notice if, on the last trading day of an”

Rain Enhancement Technologies Holdco, Inc. received a nasdaq compliance regained notice regarding other.

“November 5, 2025, Rain Enhancement Technologies Holdco, Inc. (the “Company”), received a letter from the Staff of The Nasdaq Stock Market LLC (“Nasdaq”) confirming that the Company has demonstrated compliance with the listing rules of the Nasdaq Capital Market. On October 21, 2025, Nasdaq approved the Company’s application to “phase down” the listing of its Class A common stock and warrants from the Nasdaq Global Market to the Nasdaq Capital Market. The Company’s Class A common stock will continue to trade under the symbol “RAIN” and the Company’s warrants will continue to trade under the symb”

GULF RESOURCES, INC. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2)).

“November 4, 2025, the Company received a delist determination letter from the staff (the “Staff”) of the Listing Qualifications Department of The Nasdaq Stock Market, LLC (“Nasdaq”) advising the Company that the Staff had determined that the Company did not regain compliance with Listing Rule 5550(a)(2) by the November 3, 2025 deadline. The Staff had determined that the Company’s securities will be scheduled for delisting from The Nasdaq Capital Market on November 11, 2025. As a result of effecting the Reverse Stock Split (as defined below) and timely filing the Appeal (as defined below), the”

Lunai Bioworks Inc. received a nasdaq compliance regained notice regarding shareholders (rules 5620(a)).

“otifying the Company that it was no longer in compliance with Nasdaq Listing Rule 5620(a), which requires that listed companies hold an annual meeting of shareholders no later than one year after the end of their fiscal year.”

Purple Innovation, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).

“November 5, 2025, Purple Innovation, Inc. (the “Company”) received written notice from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) that the Company is not in compliance with Nasdaq Listing Rule 5450(a)(1), as the closing bid price of the Company’s common stock has been below the required minimum of $1.00 per share for 30 consecutive business days. The notification of noncompliance has no immediate effect on the listing or trading of the Company’s Class A common stock on The Nasdaq Global Select Market. The Company has 180 calendar days, or until May 4, 2026, to”

BONK, INC. received a nasdaq deficiency notice notice regarding other (rules 5635(b), 5640, 5250(e)).

“) that the previously disclosed private placements that the Company entered into on August 8, 2025 and August 29, 2025 (the “Transactions”) together and individually failed to comply with the following Nasdaq Listing Rules (the “Rules”): (i) notification requirements under Listing Rules 5250(b)(1), 5250(e)(2)(B) and 5250(e)(2)(D); (ii) Shareholder Approval requirements under Listing Rules 5635(a) and 5635(b); and (iii) Voting Rights requirements under Listing Rule 5640. The Letter further stated that based on the Company’s corrective actions to amend the Transactions and subsequent disclosures”

DIH HOLDING US, INC. received a nasdaq delisting notice notice regarding other (rules 5250(c)(1), 5450(a)(1), 5450(b), 5450(b)(2)(A)).

“November 5, 2025, DIH Holding US, Inc. (the “Company”) received a determination letter from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Nasdaq Hearings Panel (the “Panel”) has determined to deny the Company’s request to continue its listing on Nasdaq. Accordingly, the Company’s shares will be delisted from Nasdaq and trading in the Company’s securities will be suspended at the open of trading on November 7, 2025. As previously disclosed, the Listing Qualifications Staff (“Staff”) of Nasdaq notified the Company that it was not in compliance with Listing Rules 5250(c)(1), 5450(a)(”

Curanex Pharmaceuticals Inc received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“November 5, 2025, Curanex Pharmaceuticals Inc, a Nevada corporation (the “Company”), received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that for the last 30 consecutive business days the closing bid price for the Company’s common stock, par value $0.0001 per share (the “Common Stock”), was below $1.00 per share, which is the minimum closing bid price (the “Minimum Bid Price”) required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Notice”). This Notice has no immediate”

NEUROONE MEDICAL TECHNOLOGIES Corp received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2)).

“November 4, 2025, NeuroOne Medical Technologies Corporation (the “Company”) received a letter (the “Extension Notice”) from the Listing Qualifications Staff of The Nasdaq Stock Market, LLC (“Nasdaq”) notifying the Company that Nasdaq has granted the Company a 180-day extension, until May 4, 2026 (the “Extension Period”), to regain compliance with the requirement for the Company’s common stock, par value $0.001 per share (“Common Stock”), to maintain a minimum bid price of $1.00 per share for continued listing on the Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Mi”

Bowen Acquisition Corp received a nasdaq delisting notice notice regarding other (rules 5450(b)(2)(A), 5450(b)(2)(B), 5450(b)(2)(C), 5450(a)(2), 5101).

“July 15, 2025, the Company received a delisting determination letter (the “Delisting Determination Letter”) notifying the Company that its securities are now subject to delisting from the Nasdaq Global Market. The Delisting Determination Letter stated that the Company was not in compliance with (A) Nasdaq Listing Rules 5450(b)(2)(A), which requires companies listed on the Nasdaq Global Market to have Market Value of Listed Securities of at least $50,000,000 for a period of 30 consecutive trading days, (B) Nasdaq Listing Rules 5450(b)(2)(B), which requires that companies listed on the Nasdaq Gl”

ESH Acquisition Corp. received a nasdaq noncompliance notice notice regarding market value (rules 5450(b)(2)(A)).

“sdaq stating that, for the prior 30 consecutive business days (through April 10, 2025), the closing market value of listed securities (MVLS) of the Company’s Class A Shares had been below the minimum of $50 million required for continued listing on the Nasdaq Global Market under Nasdaq Listing Rule 5450(b)(2)(A). In response, the Company filed an application to transfer the listing of its Class A Shares from the Nasdaq Global Market to the Nasdaq Capital Market, which requires an MVLS of $35 million for continued listing. - 1 - SIGNATURE Pursuant to the requirements of the Securities Exchange”

Profusa, Inc. received a nasdaq noncompliance notice notice regarding market value (rules 5450(b)(2)(C), 5810(c)(3)(D)).

“October 27, 2025, Profusa, Inc. (the “Company”) received a notification letter (the “Notification Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that the Company is not in compliance with the continued listing requirement to maintain a minimum Market Value of Publicly Held Shares (“MVPHS”) of $15,000,000 for the Nasdaq Global Market, as set forth in Nasdaq Listing Rule 5450(b)(2)(C). Nasdaq’s determination was based on the Company’s MVPHS having been below $15,000,000 for the prior 30 consecutive business days from September 12, 2025 throug”

Elite Express Holding Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“October 31, 2025, Elite Express Holding Inc. (the “Company”) received a notification letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”). The Notice informed the Company that, for the last 30 consecutive business days, the closing bid price for the Company’s Class A common stock, par value $0.000001 per share (the “Common Stock”), was below $1.00 per share, which is the minimum closing bid price required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2). The Notice has no immediate effect on the”

urban-gro, Inc. received a nasdaq hearing update notice regarding late filing (rules 5250(c)(1)).

“October 30, 2025, the Company received a notice from Nasdaq notifying the Company that the Panel had determined to grant the Company’s request to continue its listing on The Nasdaq Capital Market, subject to certain conditions. Specifically, the Panel conditioned the Company’s continued listing on the Company regaining compliance with the Timely Filing Requirement and the Stockholders’ Equity Requirement on or before December 31, 2025 and regaining compliance with the Bid Price Rule on or before January 28, 2026. During the exception period, the Company is required to provide prompt notificati”

urban-gro, Inc. received a nasdaq hearing update notice regarding minimum bid price (rules 5550(a)(2)).

“October 30, 2025, the Company received a notice from Nasdaq notifying the Company that the Panel had determined to grant the Company’s request to continue its listing on The Nasdaq Capital Market, subject to certain conditions. Specifically, the Panel conditioned the Company’s continued listing on the Company regaining compliance with the Timely Filing Requirement and the Stockholders’ Equity Requirement on or before December 31, 2025 and regaining compliance with the Bid Price Rule on or before January 28, 2026. During the exception period, the Company is required to provide prompt notificati”

Nuvve Holding Corp. received a nasdaq extension granted notice regarding stockholders equity.

“October 28, 2025, the Panel informed the Company that it had granted the Company’s requested extension to regain compliance by December 31, 2025, subject to certain conditions and requirements as a result of the hearing with the Panel. While the Company intends to pursue its plan to regain compliance as presented to the Panel, there can be no assurance that the Company will be able to regain compliance and thereafter maintain its listing on Nasdaq. Forward-Looking Statements This Current Report on Form 8-K contains certain “forward-looking statements” within the meaning of the Securities Act o”

Nuvve Holding Corp. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)(iv)).

“October 28, 2025, the Panel informed the Company that it had granted the Company’s requested extension to regain compliance by December 31, 2025, subject to certain conditions and requirements as a result of the hearing with the Panel. While the Company intends to pursue its plan to regain compliance as presented to the Panel, there can be no assurance that the Company will be able to regain compliance and thereafter maintain its listing on Nasdaq. Forward-Looking Statements This Current Report on Form 8-K contains certain “forward-looking statements” within the meaning of the Securities Act o”

NextPlat Corp received a nasdaq extension granted notice regarding minimum bid price (rules 5450(a)(1)).

“October 28, 2025, the Company received a letter from the Staff notifying that the Company is eligible for a second 180-day period, or until April 27, 2026 (the “Second Grace Period”) to regain compliance with the Bid Price Requirement. According to the notification from Nasdaq, the Staff’s determination was based on (i) the Company meeting the continued listing requirement for market value of its publicly held shares and all other Nasdaq initial listing standards, with the exception of the Bid Price Requirement, and (ii) the Company’s written notice to Nasdaq of its intention to cure the defic”

NextPlat Corp received a nasdaq extension granted notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).

“October 28, 2025, the Company received a letter from the Staff notifying that the Company is eligible for a second 180-day period, or until April 27, 2026 (the “Second Grace Period”) to regain compliance with the Bid Price Requirement. According to the notification from Nasdaq, the Staff’s determination was based on (i) the Company meeting the continued listing requirement for market value of its publicly held shares and all other Nasdaq initial listing standards, with the exception of the Bid Price Requirement, and (ii) the Company’s written notice to Nasdaq of its intention to cure the defic”

Lunai Bioworks Inc. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2)).

“October 27, 2025, Lunai Bioworks (the “Company”) received a notification letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company is not in compliance with the $35 million minimum Market Value of Listed Securities (“MVLS”) requirement set forth in Nasdaq Listing Rule 5550(b)(2) for Capital Market. The Notice stated that the Company’s MVLS had been below $35 million for the previous 30 consecutive business days, and that, in accordance with Nasdaq rules, the Company has a period of 180 calendar days, or until April 27”

Tianci International, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“October 29, 2025, Tianci received a deficiency letter from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market (“Nasdaq”) notifying Tianci that, for the preceding 30 consecutive business days, the closing bid price for Tianci’s Common Stock was below the minimum $1.00 per share requirement for continued inclusion on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Requirement”). The notification has no immediate effect on Tianci’s Nasdaq listing. In accordance with Nasdaq rules, Tianci has been provided a period of 180 calendar day”

MOBIX LABS, INC received a nasdaq noncompliance notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“April 28, 2025 from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance with the minimum bid-price requirement for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid-Price Requirement”). The notice provided the Company 180 calendar days, or until October 27, 2025, to regain compliance by maintaining a closing bid price of at least $1.00 per share for a minimum of ten consecutive business days, as provided in Nasdaq Listing Rule 5810(c)(3)(A) (the “Initial Compl”

CERO THERAPEUTICS HOLDINGS, INC. received a nasdaq delisting notice notice regarding stockholders equity (rules 5550(b)).

“October 29, 2025, the Company received the determination of the Hearings Panel to deny the Company’s request for the continued listing of its common stock. As a result, the common stock will be suspended from trading on Nasdaq at open of trading on October 31, 2025. The Company has submitted a request for review of the Hearings Panel’s decision by the Nasdaq Listing and Hearing Review Council (the “ Council ”). The Company has also commenced the process of seeking to trade its shares of common stock on the OTC Markets. However, the Company can provide no assurance that the review by the Counci”

GRAPHJET TECHNOLOGY received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(C)).

“October 29, 2025, the Company received a written notice (the “ Notice ”) from the Nasdaq Stock Market LLC (“ Nasdaq ”) indicating that because the Company did not regain compliance with Nasdaq Listing Rule 5450(b)(2)(C), requiring that the Company maintain a minimum market value of its publicly held shares of $15,000,000 for 30 consecutive trading days (the “ MVPHS Requirement ”), by October 22, 2025, Nasdaq will consider this deficiency in their decision regarding the Company’s continued listing on the Nasdaq Global Market. The Notice further stated that the Company also does not currently sa”

SANGAMO THERAPEUTICS, INC received a nasdaq extension granted notice regarding minimum bid price (rules 5810(c)(3)(A)).

“October 29, 2025, Sangamo Therapeutics, Inc. (the “Company”) received a letter (the “Extension Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) advising that the Company has been granted a 180-day extension, or until April 27, 2026, to regain compliance with the requirement to maintain a minimum bid price of $1.00 per share for continued listing on The Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”), in accordance with Nasdaq Listing Rule 5810(c)(3)(A). If at any time prior to April 27, 2026, the bid price of the Company’s common”

TON Strategy Co received a nasdaq noncompliance notice notice regarding other (rules 5635(a), 5635(b)).

“October 28, 2025, TON Strategy Company (the “Company”) received a Letter of Reprimand (the “Reprimand Letter”) from the staff at the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) in connection with the Staff’s determination that the Company had violated Nasdaq’s shareholder approval requirements set forth in Nasdaq Listing Rules 5635(a) and 5635(b) (the “Rules”). The Reprimand Letter stated that while the Staff determined that there were failures to comply with the Rules, those failures did not appear to have been the result of a deliberate intent to”